Skip to main content
Home
Zeitschriften
Zeitungen
Podcast
Gesundheitspolitik
Praxis
Allerlei
Jobs
Fachgebiete
Allgemeinmedizin Anästhesiologie & Intensivmedizin Apotheke Augenheilkunde Chirurgie Dermatologie Gynäkologie und Geburtshilfe HNO Innere Medizin Kinder & Jugendheilkunde Neurologie & Psychiatrie Orthopädie & Unfallchirurgie Pflege Urologie Zahnmedizin
Subfächer Innere Medizin
Diabetologie Gastroenterologie Infektiologie Kardiologie Onkologie und Hämatologie Pneumologie Rheumatologie
Fortbildungen
Überblick Fortbildungen DFP-Literaturstudium-Artikel DFP-Webcast Fortbildungen DFP-Podcasts
Erweiterte Suche
Anmelden
nach oben
European Surgery
Erschienen in:

01.06.2013 | Main Topic

The use of Keratinocytes: Things we should keep in mind!

verfasst von: A. S. Moghaddam, PhD, L. P. Kamolz, MD, MSc, W. Weninger, D. Parvizi, MD, M. Wiedner, D. B. Lumenta, MD

Erschienen in: European Surgery | Ausgabe 3/2013

Einloggen, um Zugang zu erhalten

Summary

Background

Cultivation of keratinocytes and their clinical application was an essential step towards the development of new treatment concepts for patients suffering from severe burns and chronic cutaneous wounds. The aim of this review is to give a current overview of keratinocyte cultivation and keratinocyte application under experimental and clinical conditions as well as to discuss their limitations, complications and future perspectives.

Methods

Pubmed and Medline was systematically searched for correlative publications.

Results

Promising at first, but over time its limitations became evident: demanding infrastructural requirements, high costs, lack of “ex-vitro” stability, additional requirement for dermal support, and the absence of other skin cell types or appendages have limited the introduction in daily clinical routine. Nonetheless, continuous efforts have been made in the past decades in order to improve the application of keratinocytes. Novel techniques of keratinocyte harvest and cultivation have simplified the clinical application, improved stability, and consequent outcomes.

Conclusions

The herein presented efforts despite their drawbacks during the development process and resultant clinical outcomes of keratinocyte culturing bear a solid foundation for the future. The ultimate challenge however remains, bringing any of these efforts into clinical practice while avoiding the failures of the past.
Vorheriger Artikel Articular cartilage tissue regeneration—current research strategies and outlook for the future
Nächster Artikel Tissue engineering in thoracic surgery
Literatur
1.
Kamolz LP, Lumenta DB, Kitzinger HB, Frey M. Tissue engineering for cutaneous wounds: an overview of current standards and possibilities. Eur Surg. 2008;40:19–26.CrossRef
2.
Metcalfe AD, Ferguson MW. Tissue engineering of replacement skin. The crossroads of biomaterials, wound healing, embryonic development, stem cells and regeneration. J R Soc Interface. 2007;4:413–37.PubMedCrossRef
3.
Bell E, Ehrlich HP, Buttle DJ, Nakatsuji T. Living tissue formed in vitro and accepted as skin-equivalent tissue of full thickness. Science. 1981;211:1052–4.PubMedCrossRef
4.
Jensen PKA, Bolund L. Tissue culture of human epidermal keratinocytes: a differentiating model system for gene testing and somatic gene therapy. J Cell Sci. 1991;100:255–9.PubMed
5.
Anderson BE. The netter collection of medical illustrations: integumentary system, 2nd ed. Philadelphia: Saunders; 2012.
6.
Wong DJ, Chang HY. Skin tissue engineering, ed The Stem Cell Research Community StemBook; 2009.
7.
Abdel-Naser MB, Abdallah M, Almeida HLD Jr., Wollina U. Human skin cell culture and its impact on dermatology. EDOJ. 2005;1(2):1–25.
8.
Pomahac B, Svensjo T, Yao F, Brown H, Eriksson E. Tissue engineering of skin. Crit Rev Oral Biol Med. 1998;9:333–44.PubMedCrossRef
9.
Rheinwald JG, Green H. Serial cultivation of strains of human epidermal keratinocytes. The formation of keratinizing colonies from single cells. Cell. 1975;6:331–43.PubMedCrossRef
10.
Rheinwald JG, Green H. Epidermal growth factor and the multiplication of cultured human epidermal keratinocytes. Nature. 1977;265:421–4.PubMedCrossRef
11.
Clugston PA, Snelling CF, Macdonald IB, Maledy HL, Boyle JC, Germann E, Courtemanche AD, Wirtz P, Fitzpatrick DJ, Kester DA, et al. Cultured epithelial autografts: three years of clinical experience with eighteen patients. J Burn Care Rehabil. 1991;12:533-9.PubMedCrossRef
12.
Gallico GG, O’Connor NE, Compton CC, Kehinde O, Green H. Permanent coverage of large burn wounds with autologous cultured human epithelium. N Engl J Med. 1984;311:48–451.CrossRef
13.
O’Connor NE. Grafting of burns with cultured epithelium prepared from autologous epidermal cells. Lancet. 1981;1:75–8.
14.
Cuono C, Langdon R, McGuire J. Use of cultured epidermal autografts and dermal allografts as skin replacement after burn injury. Lancet. 1986;1:1123–4.PubMedCrossRef
15.
Heimbach DM. A nonuser’s questions about cultured epidermal autograft. J Burn Care Rehabil. 1992;13:127–9.PubMedCrossRef
16.
Burke JF, Yannas IV, Quinby WC, Jr., Bondoc CC, Jung WK. Successful use of a physiologically acceptable artificial skin in the treatment of extensive burn injury. Ann Surg. 1981;194:413–28.PubMedCrossRef
17.
Boyce ST, Goretsky MJ, Greenhalgh DG, Kagan RJ, Rieman MT, Warden GD. Comparative assessment of cultured skin substitutes and native skin autograft for treatment of full-thickness burns. Ann Surg. 1995;222:743–52.PubMedCrossRef
18.
Supp DM, Boyce ST. Engineered skin substitutes: practices and potentials. Clin Dermatol. 2005;23:403–12.PubMedCrossRef
19.
Lootens L, Brusselaers N, Beele H, Monstrey S. Keratinocytes in the treatment of severe burn injury: an update. Int Wound J. 2013;10:6–12.
20.
Carsin H, Ainaud P, Le Bever H, Rives J, Lakhel A, Stephanazzi J, Lambert F, Perrot J. Cultured epithelial autografts in extensive burn coverage of severely traumatized patients: a five year single-center experience with 30 patients. Burns. 2000;26:379–87.PubMedCrossRef
21.
Herndon D. Total burn care, 3rd ed. Philadelphia: Saunders Elsevier press; 2007.
22.
Maas-Szabowski N, Shimotoyodome A, Fusenig NE. Keratinocyte growth regulation in fibroblast cocultures via a double paracrine mechanism. J Cell Sci. 1999;112 (Pt 12):1843–53.PubMed
23.
Limat A, Hunziker T, Boillat C, Bayreuther K, Noser F. Post-mitotic human dermal fibroblasts efficiently support the growth of human follicular keratinocytes. J Invest Dermatol. 1989;92:758–62.PubMedCrossRef
24.
Panacchia L, Dellambra E, Bondanza S, Paterna P, Maurelli R, Paionni E, Guerra L. Nonirradiated human fibroblasts and irradiated 3t3-j2 murine fibroblasts as a feeder layer for keratinocyte growth and differentiation in vitro on a fibrin substrate. Cells Tissues Organs. 2010;191:21–35.PubMedCrossRef
25.
Harris PA, Leigh IM, Navsaria HA. Pre-confluent keratinocyte grafting: the future for cultured skin replacements? Burns. 1998;24:591–3.PubMedCrossRef
26.
Currie LJ, Martin R, Sharpe JR, James SE. A comparison of keratinocyte cell sprays with and without fibrin glue. Burns. 2003;29:677–85.PubMedCrossRef
27.
Fredriksson C, Kratz G, Huss F. Transplantation of cultured human keratinocytes in single cell suspension: a comparative in vitro study of different application techniques. Burns. 2008;34:212–9.PubMedCrossRef
28.
Chua A, Song C, Chai A, Chan L, Tan KC. The impact of skin banking and the use of its cadaveric skin allografts for severe burn victims in singapore. Burns. 2004;30:696–700.PubMedCrossRef
29.
Hamilton KT, Herson MR. Skin bank development and critical incident response. Cell Tissue Bank 2010;12:147-151.PubMedCrossRef
30.
Pianigiani E, Ierardi F, Cherubini Di Simplicio F, Andreassi A. Skin bank organization. Clin Dermatol. 2005;23:3–356.
31.
Limat A, Mauri D, Hunziker T. Successful treatment of chronic leg ulcers with epidermal equivalents generated from cultured autologous outer root sheath cells. J Invest Dermatol. 1996;107:128–35.PubMedCrossRef
32.
Blanpain C, Fuchs E. Epidermal stem cells of the skin. Annu Rev Cell Dev Biol. 2006;22:339–73.PubMedCrossRef
33.
Limat A, Hunziker T. Use of epidermal equivalents generated from follicular outer root sheath cells in vitro and for autologous grafting of chronic wounds. Cells Tissues Organs. 2002;172:79–85.PubMedCrossRef
34.
Tausche AK, Skaria M, Bohlen L, Liebold K, Hafner J, Friedlein H, Meurer M, Goedkoop RJ, Wollina U, Salomon D, Hunziker T. An autologous epidermal equivalent tissue-engineered from follicular outer root sheath keratinocytes is as effective as split-thickness skin autograft in recalcitrant vascular leg ulcers. Wound Repair Regen. 2003;11:248–52.PubMedCrossRef
35.
36.
37.
Fujita Y, Inokuma D, Abe R, Sasaki M, Nakamura H, Shimizu T, Shimizu H. Conversion from human haematopoietic stem cells to keratinocytes requires keratinocyte secretory factors. Clin Exp Dermatol. 2012;37:658–64.PubMedCrossRef
38.
Lee SH, Lee JH, Cho KH. Effects of human adipose-derived stem cells on cutaneous wound healing in nude mice. Ann Dermatol. 2011;23:150–5.PubMedCrossRef
39.
Vatansever HS, Uluer ET, Aydede H, Ozbilgin MK. Analysis of transferred keratinocyte-like cells derived from mouse embryonic stem cells on experimental surgical skin wounds of mouse. Acta Histochem. 2013;115:32–41.
40.
Bobis S, Jarocha D, Majka M. Mesenchymal stem cells: characteristics and clinical applications. Folia Histochem Cytobiol. 2006;44:215–30.PubMed
41.
Zografou A, Tsigris C, Papadopoulos O, Kavantzas N, Patsouris E, Donta I, Perrea D. Improvement of skin-graft survival after autologous transplantation of adipose-derived stem cells in rats. J Plast Reconstr Aesthet Surg. 2011;64:1647–56.PubMedCrossRef
42.
Brittan M, Braun KM, Reynolds LE, Conti FJ, Reynolds AR, Poulsom R, Alison MR, Wright NA, Hodivala-Dilke KM. Bone marrow cells engraft within the epidermis and proliferate in vivo with no evidence of cell fusion. J Pathol. 2005;205:1–13.PubMedCrossRef
43.
Wu Y, Zhao RC, Tredget EE. Concise review: bone marrow-derived stem/progenitor cells in cutaneous repair and regeneration. Stem Cells. 2010;28:905–15.PubMed
44.
Kamolz LP, Kolbus A, Wick N, Mazal PR, Eisenbock B, Burjak S, Meissl G. Cultured human epithelium: human umbilical cord blood stem cells differentiate into keratinocytes under in vitro conditions. Burns. 2006;32:16–19.PubMedCrossRef
45.
Burd A, Ahmed K, Lam S, Ayyappan T, Huang L. Stem cell strategies in burns care. Burns. 2007;33:282–91.PubMedCrossRef
46.
James SE, Booth S, Dheansa B, Mann DJ, Reid MJ, Shevchenko RV, Gilbert PM. Sprayed cultured autologous keratinocytes used alone or in combination with meshed autografts to accelerate wound closure in difficult-to-heal burns patients. Burns. 2010;36:e10–20.PubMedCrossRef
47.
Kopp J, Jeschke MG, Bach AD, Kneser U, Horch RE. Applied tissue engineering in the closure of severe burns and chronic wounds using cultured human autologous keratinocytes in a natural fibrin matrix. Cell Tissue Bank. 2004;5:89–96.PubMedCrossRef
48.
Hernon CA, Dawson RA, Freedlander E, Short R, Haddow DB, Brotherston M, MacNeil S. Clinical experience using cultured epithelial autografts leads to an alternative methodology for transferring skin cells from the laboratory to the patient. Regen Med. 2006;1:809–21.PubMedCrossRef
49.
Munster AM. Cultured skin for massive burns. A prospective, controlled trial. Ann Surg. 1996;224:372–5; discussion 375–7.PubMedCrossRef
50.
Ichioka S, Kouraba S, Sekiya N, Ohura N, Nakatsuka T. Bone marrow-impregnated collagen matrix for wound healing: experimental evaluation in a microcirculatory model of angiogenesis, and clinical experience. Br J Plast Surg. 2005;58:1124–30.PubMedCrossRef
51.
Jin G, Prabhakaran MP, Ramakrishna S. Stem cell differentiation to epidermal lineages on electrospun nanofibrous substrates for skin tissue engineering. Acta Biomater. 2011;7:3113–22.PubMedCrossRef
52.
Philandrianos C, Andrac-Meyer L, Mordon S, Feuerstein JM, Sabatier F, Veran J, Magalon G, Casanova D. Comparison of five dermal substitutes in full-thickness skin wound healing in a porcine model. Burns. 2012;38:820–9.PubMedCrossRef
53.
Ronfard V, Rives JM, Neveux Y, Carsin H, Barrandon Y. Long-term regeneration of human epidermis on third degree burns transplanted with autologous cultured epithelium grown on a fibrin matrix. Transplantation. 2000;70:1588–98.PubMedCrossRef
54.
Truong AT, Kowal-Vern A, Latenser BA, Wiley DE, Walter RJ. Comparison of dermal substitutes in wound healing utilizing a nude mouse model. J Burns Wounds. 2005;4:e4.PubMed
55.
Chester DL, Balderson DS, Papini RP. A review of keratinocyte delivery to the wound bed. J Burn Care Rehabil. 2004;25:266–75.PubMedCrossRef
56.
Paddle-Ledinek JE, Cruickshank DG, Masterton JP. Skin replacement by cultured keratinocyte grafts: an Australian experience. Burns. 1997;23:204–11.PubMedCrossRef
57.
Wood FM, Giles N, Stevenson A, Rea S, Fear M. Characterisation of the cell suspension harvested from the dermal epidermal junction using a recell(r) kit. Burns 2012;38:44–51.PubMedCrossRef
58.
Eves PC, Beck AJ, Shard AG, Mac Neil S. A chemically defined surface for the co-culture of melanocytes and keratinocytes. Biomaterials. 2005;26:7068–81.PubMedCrossRef
59.
Theopold C, Hoeller D, Velander P, Demling R, Eriksson E. Graft site malignancy following treatment of full-thickness burn with cultured epidermal autograft. Plast Reconstr Surg. 2004;114:1215–9.PubMed
60.
Auxenfans C, Fradette J, Lequeux C, Germain L, Kinikoglu B, Bechetoille N, Braye F, Auger FA, Damour O. Evolution of three dimensional skin equivalent models reconstructed in vitro by tissue engineering. Eur J Dermatol. 2009;19:107–13.PubMed
61.
Kim JY, Park CD, Lee JH, Lee CH, Do BR, Lee AY. Co-culture of melanocytes with adipose-derived stem cells as a potential substitute for co-culture with keratinocytes. Acta Derm Venereol. 2011;92:16–23.
62.
Michel M, L’Heureux N, Pouliot R, Xu W, Auger FA, Germain L. Characterization of a new tissue-engineered human skin equivalent with hair. In Vitro Cell Dev Biol Anim. 1999;35:318–26.PubMedCrossRef
63.
Lugo LM, Lei P, Andreadis ST. Vascularization of the dermal support enhances wound re-epithelialization by in situ delivery of epidermal keratinocytes. Tissue Eng Part A 2011;17:665–75.PubMedCrossRef
64.
Vermette M, Trottier V, Menard V, Saint-Pierre L, Roy A, Fradette J. Production of a new tissue-engineered adipose substitute from human adipose-derived stromal cells. Biomaterials. 2007;28:2850–60.PubMedCrossRef
Metadaten
Titel
The use of Keratinocytes: Things we should keep in mind!
verfasst von
A. S. Moghaddam, PhD
L. P. Kamolz, MD, MSc
W. Weninger
D. Parvizi, MD
M. Wiedner
D. B. Lumenta, MD
Publikationsdatum
01.06.2013
Verlag
Springer Vienna
Erschienen in
European Surgery / Ausgabe 3/2013
Print ISSN: 1682-8631
Elektronische ISSN: 1682-4016
DOI
https://doi.org/10.1007/s10353-013-0204-1

Weitere Artikel der Ausgabe 3/2013

Gemcitabine-based neoadjuvant chemotherapy for locally advanced pancreatic cancer does not affect mortality and morbidity after pancreatic resection

  • Original Article

Fatal arterial complications following ultrasound-guided attempt of internal jugular vein catheterization

  • Case Report

Applications of tissue engineering in modern laryngology


  • Main Topic

Concentrated sugar belongs to the museum

  • Editorial

Tissue engineering and its potential use in surgery

  • Editorial

Erratum to: Effects of everolimus on hepatic ischemia/reperfusion injury in an experimental rat model

  • Erratum